CONMED CORP's ticker is and the CUSIP is 207410AF8. A total of 25 filers reported holding CONMED CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $53,015 | – | 46,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABSOLUTE INVESTMENT ADVISERS, LLC | 4,115,000 | $4,708,428 | 0.71% |
| ZAZOVE ASSOCIATES LLC | 5,455,000 | $6,306 | 0.58% |
| SHENKMAN CAPITAL MANAGEMENT INC | 4,076,000 | $4,644,575 | 0.29% |
| MACKAY SHIELDS LLC | 6,287,000 | $7,123,996 | 0.18% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 15,994,000 | $18,201,172 | 0.13% |
| WOLVERINE ASSET MANAGEMENT LLC | 8,997,000 | $10,397,505 | 0.11% |
| Teton Advisors, Inc. | 350,000 | $404,604 | 0.10% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,264,000 | $3,759,802 | 0.10% |
| Calamos Wealth Management LLC | 384,000 | $436,992 | 0.03% |
| GABELLI FUNDS LLC | 3,000,000 | $3,468,030 | 0.03% |